SBFM.US Sunshine Biopharma Inc

Healthcare Biotechnology USA Stocks
2.51 USD
Close of Nov 17, 2026
2.51 464.00
Market cap
USD 2.07M
P/E
-
P/B
0.08x
ROE
-18.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is SBFM.US undervalued?

Graham number

The Graham number of Sunshine Biopharma Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Sunshine Biopharma Inc fundamental analysis

No fundamental analysis for Sunshine Biopharma Inc yet.

Sunshine Biopharma Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Sunshine Biopharma Inc

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under …

Full company profile